By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
CHOOSE YOUR LANGUAGE
CHOOSE YOUR LANGUAGE
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466
China's strong determination in chronic disease prevention and control, as well as its clear policy goals and actions, are highly admirable, said Helge Lund, chairman of global pharmaceutical giant Novo Nordisk, in an interview with CMG. He added that his company will continue to contribute to the Chinese healthcare market.